OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
November 01, 2019
Contract manufacturers are making strategic partnerships and expanding services in the last quarter of 2019.
September 01, 2019
CDMOs are adding facilities and services to their portfolios in anticipation of the biologics industry’s continued growth.
July 01, 2019
The increasing growth in the cell- and gene-therapy markets is inspiring CDMOs to expand their services in this emerging biologic drug arena.
May 01, 2019
FDA inspections can create uncertainty. Supervision of the contract manufacturer
is crucial in ensuring compliance.
March 01, 2019
Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.
January 01, 2019
Outsourcing of manufacturing activities is expected to increase in 2019.
November 01, 2018
The growth in adoption of single-use systems for commercial manufacturing will be dramatic in coming years.
September 01, 2018
Partnerships, mergers, and new services indicate that biologics are continuing to influence CMOs’ and CDMOs’ decisions to expand their biopharmaceutical services.
July 01, 2018
This article highlights 15 years of changes in biopharmaceutical manufacturing.
June 01, 2018
New and expanded facilities point to the continuing growth of the biopharmaceutical industry.